Csuk R - Search Results

1

Pavel IZ, Heller L, Sommerwerk S, Loesche A, Al-Harrasi A, Csuk R. Pavel IZ, et al. Among authors: csuk r. Arch Pharm (Weinheim). 2017 Jan;350(1). doi: 10.1002/ardp.201600289. Epub 2016 Nov 23. Arch Pharm (Weinheim). 2017. PMID: 27879007

2

Synthesis of dimeric trifluoromethoxyacridine-derived pathogen-inactivating nucleic acid intercalators.

Csuk R, Raschke C, Göthe G, Reissmann S. Csuk R, et al. Arch Pharm (Weinheim). 2004 Nov;337(11):571-8. doi: 10.1002/ardp.200400907. Arch Pharm (Weinheim). 2004. PMID: 15540226

3

Synthesis of dimeric quinazolin-2-one, 1,4-benzodiazepin-2-one, and isoalloxazine compounds as inhibitors of amyloid peptides association.

Barthel A, Trieschmann L, Ströhl D, Kluge R, Böhm G, Csuk R. Barthel A, et al. Among authors: csuk r. Arch Pharm (Weinheim). 2009 Aug;342(8):445-52. doi: 10.1002/ardp.200800196. Arch Pharm (Weinheim). 2009. PMID: 19565599

4

Antitumoractive endoperoxides from triterpenes.

Niesen A, Barthel A, Kluge R, Köwitzsch A, Ströhl D, Schwarz S, Csuk R. Niesen A, et al. Among authors: csuk r. Arch Pharm (Weinheim). 2009 Oct;342(10):569-76. doi: 10.1002/ardp.200900051. Arch Pharm (Weinheim). 2009. PMID: 19705376

5

Synthesis of monomeric and dimeric acridine compounds as potential therapeutics in Alzheimer and prion diseases.

Csuk R, Barthel A, Raschke C, Kluge R, Ströhl D, Trieschmann L, Böhm G. Csuk R, et al. Arch Pharm (Weinheim). 2009 Dec;342(12):699-709. doi: 10.1002/ardp.200900065. Arch Pharm (Weinheim). 2009. PMID: 19899100

6

Difluorotetrahydropyridothiazinone: a selective β-galactosidase inhibitor.

Csuk R, Prell E. Csuk R, et al. Arch Pharm (Weinheim). 2010 Oct;343(10):577-82. doi: 10.1002/ardp.200900307. Arch Pharm (Weinheim). 2010. PMID: 20925095

7

Synthesis and antitumour activity of glycyrrhetinic acid derivatives.

Schwarz S, Csuk R. Schwarz S, et al. Among authors: csuk r. Bioorg Med Chem. 2010 Nov 1;18(21):7458-74. doi: 10.1016/j.bmc.2010.08.054. Epub 2010 Sep 18. Bioorg Med Chem. 2010. PMID: 20932766

8

Amplification of the inhibitory activity and reversal of the selectivity of miglitol by C(2')-monofluorination.

Prell E, Korb C, Kluge R, Ströhl D, Csuk R. Prell E, et al. Among authors: csuk r. Arch Pharm (Weinheim). 2010 Oct;343(10):583-9. doi: 10.1002/ardp.200900256. Arch Pharm (Weinheim). 2010. PMID: 20941728

9

Synthesis, encapsulation and antitumor activity of new betulin derivatives.

Csuk R, Barthel A, Sczepek R, Siewert B, Schwarz S. Csuk R, et al. Arch Pharm (Weinheim). 2011 Jan;344(1):37-49. doi: 10.1002/ardp.201000232. Epub 2010 Dec 16. Arch Pharm (Weinheim). 2011. PMID: 21213350

10

Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids.

Csuk R, Schwarz S, Kluge R, Ströhl D. Csuk R, et al. Arch Pharm (Weinheim). 2011 Aug;344(8):505-13. doi: 10.1002/ardp.201100030. Epub 2011 Jun 14. Arch Pharm (Weinheim). 2011. PMID: 21674592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters